Companies
/Healthcare
Azenta Inc
$39.06
▼ $2.21 (−5.36%) today
Markets closed · 5:09pm ET
24/7 Wall St. View
AZTA at a Glance
Valuation
- Market cap
- $1.7B
Profitability
- Revenue (TTM)
- $613.8M
- Profit margin
- -20.0%
- EPS (TTM)
- $-2.47
Price
- 52-week range
- $16 – $46
- 24/7 target
- $44.30
- Street target
- $37.80
Earnings
- Next report
- Nov 10, 2026
Headquartered in Burlington, MA Fiscal year ends September NASDAQ: AZTA azenta.com
About Azenta
Azenta, Inc. (Nasdaq: AZTA) is a provider of life sciences solutions worldwide, enabling life science organizations to bring breakthroughs and therapies to market. The company operates through two segments: Sample Management Solutions and Multiomics. Sample Management Solutions offers cold-chain sample management including sample repository solutions, consumables and instruments, and automated storage systems. Multiomics provides genomic and gene synthesis services including next generation sequencing, Sanger sequencing, and gene synthesis across drug development, clinical research, and advanced cell therapies. Azenta serves pharmaceutical, biotech, academic, and healthcare institutions globally through brands including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey, with operations in North America, Europe, and Asia. Updated
Frequently Asked Questions
What does Azenta do?
Azenta, Inc. (Nasdaq: AZTA) is a provider of life sciences solutions worldwide, enabling life science organizations to bring breakthroughs and therapies to market. The company operates through two segments: Sample Management Solutions and Multiomics.
What is the AZTA stock price target?
24/7 Wall St.'s 12-month price target for AZTA is $44.30, rated Buy. The Wall Street consensus target is $37.80. AZTA price prediction →